Clincosm LogoSign in Get a demo

Evaluation Study: Obsessive-compulsive Disorders in Childhood and Young Adulthood

Sponsor
Susanne Walitza (Other)
Overall Status
Recruiting
CT.gov ID
NCT04723485
Collaborator
(none)
625
Enrollment
1
Location
34
Anticipated Duration (Months)
18.4
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Obsessive-compulsive disorders are very damaging illnesses that can already manifest in childhood and adolescence. With an average prevalence from 1 - 3%, they are one of the most frequently diagnosed psychiatric illness in these age groups. With the further use of data, the treatment success can be significantly improved; causal variables/predictors can be recognized, understood and taken carefully into account. The anticipated incremental knowledge will ultimately help children and young people with obsessive-compulsive disorders to receive faster and more effective treatment.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    625 participants
    Observational Model:
    Cohort
    Time Perspective:
    Retrospective
    Official Title:
    Evaluation Study: Obsessive-compulsive Disorders in Childhood and Young Adulthood
    Actual Study Start Date :
    May 1, 2020
    Anticipated Primary Completion Date :
    Mar 1, 2023
    Anticipated Study Completion Date :
    Mar 1, 2023

    Outcome Measures

    Primary Outcome Measures

    1. Symptoms severity of obsessive and compulsive symptoms in children and adolescents [24 months]

      The clinician report questionnaire (BY-BOCS) contains 19 items designed to assess severity of obsessive and compulsive symptoms in children and adolescents.The test uses a four point scale to rate the severity of their obsessive compulsive behaviors. Higher score means a worse outcome.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    4 Years to 18 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • Children and young people from 8-18 years of age who fulfill the international classification of diseases tenth edition (ICD-10) , obsessive-compulsive disorder handled in our clinic.

    • Good German language speaking skills

    • IQ > 75

    • All study participants or their legal representative have given written permission for their experiences to be documented in the study.

    Exclusion Criteria:

    • Schizophrenia-related disorders (psychoses)

    • Missing data

    • Data sets without confirmed diagnosis

    • Purely consultaive patient interview (no therapy intervention prescribed)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Psychiatric University Clinics, Department of Child and Adolescent Psychiatry Zurich ZH Switzerland 8032

    Sponsors and Collaborators

    • Susanne Walitza

    Investigators

    • Principal Investigator: Susanne Walitza, Prof. Dr. med. Dipl.-Psych., Sponsor-Investigator

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Susanne Walitza, Head of the Department of Child and Adolescent Psychiatry, Psychiatric University Hospital, Zurich
    ClinicalTrials.gov Identifier:
    NCT04723485
    Other Study ID Numbers:
    • KJPP 2019-00230
    First Posted:
    Jan 25, 2021
    Last Update Posted:
    Mar 31, 2022
    Last Verified:
    Mar 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Compulsive Personality Disorder
    Obsessive-Compulsive Disorder

    Study Results

    No Results Posted as of Mar 31, 2022